SQL & Data Analysis
Most BA roles require SQL proficiency and basic data manipulation skills. Focus on joins, aggregations, and data cleaning techniques.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Master the core competencies that separate strong BA candidates from the rest.. Explore key insights and preparation tips to help you excel in your interview process.
Most BA roles require SQL proficiency and basic data manipulation skills. Focus on joins, aggregations, and data cleaning techniques.
Learn to design business processes, gather requirements, and create system specifications that stakeholders understand.
Requirements Gathering
Stakeholder interviews & documentation
Process Mapping
Workflow design & optimization
Data Flow Design
Information architecture & reporting
Different companies emphasize different BA skills based on their business model and industry vertical.
Meta, Google
Product analytics & user behavior analysis
JPMorgan, Goldman
Risk modeling & regulatory compliance
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 65% lower housing costs compared to San Francisco, with median home prices around $200K versus $1.2M in the Bay Area. This dramatic cost advantage allows Business Analysts to achieve superior purchasing power and quality of life while building substantial savings on comparable salaries.
Baltimore's Business Analyst market shows significantly lower saturation than major tech hubs, creating better opportunities for career advancement and competitive positioning.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States